1. In Vivo
  2. >>Leadership

Digital's Big Moment Has Arrived Say CEOs At Medtech Europe Panel

 
• By Ashley Yeo

The waiting is over and digital technologies are being adopted at pace, according to a CEOs Unfiltered panel at MedTech Europe's 2018 Forum. Connected care is at the top of the priority list, say Siemens Healthineers' Bernd Montag, AdvaMed Chairman/CVRx President and CEO Nadim Yared and former bioMerieux President and CEO Jean-Luc Bélingard, although it's not the only pressing issue on the bill.

CEOs’ panel at MTF 2018: Jean-Luc Bélingard speaking with AdvaMed’s Nadim Yared and Siemens Healthineers’ CEO Bernd Montag to his right.
CEOs’ panel at MTF 2018: Jean-Luc Bélingard speaking, with AdvaMed’s Nadim Yared and Siemens Healthineers’ CEO Bernd Montag to his left • Source: MedTech Europe Forum 2018

Digital technologies, artificial intelligence and value-based health care both create opportunities to improve health care delivery and affordability, and also provide the tools to make those positive changes happen. These were absorbing themes for the record number of medtech industry attendees at the Medtech Europe Forum 2018, convened Jan. 23-25 in Brussels, Belgium.

Connected care is no longer the future, according to a panel of CEOs comprising Siemens Healthineers' Bernd Montag, AdvaMed Chairman...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

Rising Leaders 2025: J&J’s June Lanoue On Working With A Cure In Mind

 
• By Jo Shorthouse

As president of US Hematology at J&J, June Lanoue's leadership approach focuses on improving patient outcomes and organizational development. Her career path demonstrates the role of curiosity and adaptability in health care advancement.

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By Jo Shorthouse

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

 
• By Anabel Costa-Ferreira

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

Behind The Buyout: Dispatches From The Dealmaking Table

 
• By Jo Shorthouse

In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.

More from In Vivo

Wide Of The Mark: ‘The Worst EU Medtech Predictions Have Not Come True’

 
• By Ashley Yeo

Jana Grieb, European regulatory and market access legal expert at McDermott Will & Emery, explains why the healthtech and pharma industries are warming to the new EU health commissioner as he faces calls to make the MDR more “user friendly.”

This Belgian Biotech’s Drug Cocktail Could Help Reverse Muscle Aging

 
• By Jo Shorthouse

While big pharma pours billions into creating new anti-aging molecules, a Belgian startup has taken a different path: combining existing safe drugs with AI precision. The early results suggest it might be onto something revolutionary.

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By Jo Shorthouse

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy